News for 'Samiran Panda'

Covid third wave likely to be less severe than second: ICMR

Covid third wave likely to be less severe than second: ICMR

Rediff.com16 Jul 2021

Earlier this week, the top doctors' body in the country, the Indian Medical Association, said the third wave is "inevitable and imminent", pointing out that "in many parts of the country both the government and public are complacent and engaged in mass gatherings without following Covid protocols".

India would get COVID-19 vaccine by year-end: Vardhan

India would get COVID-19 vaccine by year-end: Vardhan

Rediff.com24 Aug 2020

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

Rediff.com21 Apr 2021

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

No need to panic: Experts as Covid cases rise among kids

No need to panic: Experts as Covid cases rise among kids

Rediff.com16 Apr 2022

Kids mostly have mild illnesses and recover with just symptomatic treatment.

ICMR, Hyderabad co develop potential treatment for COVID-19

ICMR, Hyderabad co develop potential treatment for COVID-19

Rediff.com2 Oct 2020

'The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,' the apex health research body said on Thursday. The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard, Dr Samiran Panda, the head of epidemiology and communicable diseases at the ICMR said.

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Rediff.com9 Jun 2021

Raches Ella, project lead, Covid-19 vaccines at Bharat Biotech said in a series of tweets that he was 'surprised' that media and researchers were drawing conclusions based on non-peer reviewed work.

Remdesivir didn't cut mortality in Covid patients: WHO

Remdesivir didn't cut mortality in Covid patients: WHO

Rediff.com16 Oct 2020

The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.

Why is India witnessing surge in COVID-19 cases?

Why is India witnessing surge in COVID-19 cases?

Rediff.com30 Aug 2020

The country has been registering over 70,000 cases for the last four days.

Covishield produced more antibodies than Covaxin: Study

Covishield produced more antibodies than Covaxin: Study

Rediff.com7 Jun 2021

The study by a group of doctors showed that after two shots of the vaccines, 98 per cent recipients of Covishield showed antibody response, while the same was 80 per cent among Covaxin recipients. Sohini Das and Ruchika Chitravanshi report.

There may not be a second Covid peak in India: Experts

There may not be a second Covid peak in India: Experts

Rediff.com19 Dec 2020

The comments come as the country's COVID-19 caseload surpassed the one crore mark, though the number of daily cases and daily fatalities have been continuously coming down.

India's high antibody count could mean less severe Covid 3rd wave

India's high antibody count could mean less severe Covid 3rd wave

Rediff.com16 Aug 2021

While some experts believe that a large part of India is still vulnerable to the virus that could trigger a third wave, others feel the country is not likely to be engulfed by another deadly wave unless a new variant emerges.

'It is common for any virus to mutate'

'It is common for any virus to mutate'

Rediff.com22 Dec 2020

'There is no data to show this virus is more deadlier.'

Top medical body favours phased school reopening

Top medical body favours phased school reopening

Rediff.com28 Sep 2021

Evidence indicates that restoration of functioning of the education system as it was in pre-Covid times, as early as possible appears prudent in the current Indian context, they said.

New Covid lineage identified, 2nd in India after 'double mutant' virus

New Covid lineage identified, 2nd in India after 'double mutant' virus

Rediff.com22 Apr 2021

The new lineage called B.1.618 is distinct from the B.1.617, also known as the 'double mutant' virus that contains two mutations, E484Q and L245R, and is believed to be behind the powerful second COVID-19 wave sweeping through India.

Many now have immunity against Covid but...: Experts

Many now have immunity against Covid but...: Experts

Rediff.com25 Jul 2021

'Opening everything is not appropriate ... everyone has been saying the third wave is a couple of days away'

Farmers continue to converge on Delhi borders, security upped

Farmers continue to converge on Delhi borders, security upped

Rediff.com1 Dec 2020

Rejecting the Centre's offer to hold talks once they move to the Burari ground, the farmers protesting against the new agricultural reform laws have been staying put at Tikri, Singhu and Ghazipur borders.

Covid 3rd wave unlikely to be as severe as second: Study

Covid 3rd wave unlikely to be as severe as second: Study

Rediff.com25 Jun 2021

A third wave of COVID-19 -- if it occurs -- is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study.

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

Rediff.com29 Nov 2020

Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, 'manufacture and distribution', failing which legal action would be taken.

Govt allows round-the-clock vaccination against COVID-19

Govt allows round-the-clock vaccination against COVID-19

Rediff.com4 Mar 2021

Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.

Superspreader protest? Farmers defiant as experts fear COVID-19 surge

Superspreader protest? Farmers defiant as experts fear COVID-19 surge

Rediff.com30 Nov 2020

There had been few signs of social distancing as thousands of farmers from Punjab and Haryana began their protest last week against the three new agro-marketing laws, setting off on a march to the national capital.

Omicron: 200 Million Indians Yet To Be Vaccinated

Omicron: 200 Million Indians Yet To Be Vaccinated

Rediff.com24 Dec 2021

We need to give a booster shot to all our frontline workers first as if they fall victim to Omicron, the health system will collapse, points out Ramesh Menon.

Govt advances meeting with protesting farmers to Dec 1

Govt advances meeting with protesting farmers to Dec 1

Rediff.com1 Dec 2020

The development came a day after the protesting farmers rejected the Centre's offer to start talks as soon as they move to Burari and continued to stay put Singhu and Tikri borders of the national capital.